Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2019 Dec;8(4):231-234.
doi: 10.1055/s-0039-1691812. Epub 2019 May 28.

Mitochondrial m.13513G>A Point Mutation in ND5 in a 16-Year-Old Man with Leber Hereditary Optic Neuropathy Detected by Next-Generation Sequencing

Affiliations
Case Reports

Mitochondrial m.13513G>A Point Mutation in ND5 in a 16-Year-Old Man with Leber Hereditary Optic Neuropathy Detected by Next-Generation Sequencing

Daniel Vázquez-Justes et al. J Pediatr Genet. 2019 Dec.

Abstract

This article reports a Leber hereditary optic neuropathy (LHON) case associated for the first time with mitochondrial m.13513G>A mutation. We present a 16-year-old man who complained of subacute, painless, visual loss. Ocular examination showed optic nerve atrophy, papillary pseudoedema, and optic disc pallor. Extraocular manifestations included hypertrophic myocardiopathy and myopathy. Initial genetic analysis excluded the three most common LHON mutations. Sanger sequencing of the whole mitochondrial deoxyribonucleic acid showed no mutation. Next-generation sequencing (NGS) revealed m.13513G>A mutation in the NADH dehydrogenase (ND5) subunit gene ( MT-ND5 ). The m.13513G>A mutation has never been associated with LHON phenotype without Leigh/mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes features. NGS techniques should be considered when this diagnosis is strongly suspected.

Keywords: Leber hereditary optic neuropathy; next-generation sequencing; whole genome sequencing.

PubMed Disclaimer

Conflict of interest statement

Conflict of Interest None declared.

Figures

Fig. 1
Fig. 1
Sanger confirmation of the m.13513G>A.

References

    1. Fraser J A, Biousse V, Newman N J. The neuro-ophthalmology of mitochondrial disease. Surv Ophthalmol. 2010;55(04):299–334. - PMC - PubMed
    1. Chacón-Camacho O F, Zenteno J C. Gene therapy for vision restoration in patients with Leber congenital amaurosis (LCA) due to RPE65 gene mutations: beginning the phase IV trial [article in Spanish] Gac Med Mex. 2017;153(02):276–278. - PubMed
    1. Mitchell A L, Elson J L, Howell N, Taylor R W, Turnbull D M. Sequence variation in mitochondrial complex I genes: mutation or polymorphism? J Med Genet. 2006;43(02):175–179. - PMC - PubMed
    1. Santorelli F M, Tanji K, Kulikova R et al.Identification of a novel mutation in the mtDNA ND5 gene associated with MELAS. Biochem Biophys Res Commun. 1997;238(02):326–328. - PubMed
    1. Kirby D M, Boneh A, Chow C W et al.Low mutant load of mitochondrial DNA G13513A mutation can cause Leigh's disease. Ann Neurol. 2003;54(04):473–478. - PubMed

Publication types